|
1
|
Rowley JD: Letter: A new consistent
chromosomal abnormality in chronic myelogenous leukaemia identified
by quinacrine fluorescence and Giemsa staining. Nature.
243:290–293. 1973. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
McLaughlin J, Chianese E and Witte ON: In
vitro transformation of immature hematopoietic cells by the P210
BCR/ABL oncogene product of the philadelphia chromosome. Proc Natl
Acad Sci USA. 84:pp. 6558–6562. 1987; View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Slupianek A, Falinski R, Znojek P,
Stoklosa T, Flis S, Doneddu V, Pytel D, Synowiec E, Blasiak J,
Bellacosa A and Skorski T: BCR-ABL1 kinase inhibits uracil DNA
glycosylase UNG2 to enhance oxidative DNA damage and stimulate
genomic instability. Leukemia. 27:629–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SJ, Jung KH, Yan HH, Son MK, Fang Z,
Ryu YL, Lee H, Lim JH, Suh JK, Kim J, et al: HS-543 induces
apoptosis of Imatinib-resistant chronic myelogenous leukemia with
T315I mutation. Oncotarget. 6:1507–1518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bu Q, Cui L, Li J, Du X, Zou W, Ding K and
Pan J: SAHA and S116836, a novel tyrosine kinase inhibitor,
synergistically induce apoptosis in imatinib-resistant chronic
myelogenous leukemia cells. Cancer Biol Ther. 15:951–962. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Senior M: FDA halts then allows sales of
Ariad's leukemia medication. Nat Biotechnol. 32:9–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung RC: Treatment of intestinal parasitic
disease. South Med J. 69:799–804. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lamb R, Ozsvari B, Lisanti CL, Tanowitz
HB, Howell A, Martinez-Outschoorn UE, Sotgia F and Lisanti MP:
Antibiotics that target mitochondria effectively eradicate cancer
stem cells, across multiple tumor types: Treating cancer like an
infectious disease. Oncotarget. 6:4569–4584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu W, Lacerda L, Debeb BG, Atkinson RL,
Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, et al: The
antihelmintic drug pyrvinium pamoate targets aggressive breast
cancer. PLoS One. 8:e715082013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng L, Lei Y, Liu R, Li J, Yuan K, Li Y,
Chen Y, Liu Y, Lu Y, Edwards CK III, et al: Pyrvinium targets
autophagy addiction to promote cancer cell death. Cell Death Dis.
4:e6142013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harada Y, Ishii I, Hatake K and Kasahara
T: Pyrvinium pamoate inhibits proliferation of
myeloma/erythroleukemia cells by suppressing mitochondrial
respiratory complex I and STAT3. Cancer Lett. 319:83–88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu DH, Macdonald J, Liu G, Lee AS, Ly M,
Davis T, Ke N, Zhou D, Wong-Staal F and Li QX: Pyrvinium targets
the unfolded protein response to hypoglycemia and its anti-tumor
activity is enhanced by combination therapy. PLoS One. 3:e39512008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thorne CA, Hanson AJ, Schneider J, Tahinci
E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson
AG, et al: Small-molecule inhibition of Wnt signaling through
activation of casein kinase 1α. Nat Chem Biol. 6:829–836. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li B, Fei DL, Flaveny CA, Dahmane N,
Baubet V, Wang Z, Bai F, Pei XH, Rodriguez-Blanco J, Hang B, et al:
Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Cancer Res. 74:4811–4821. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Flaveny CA, Giambelli C, Fei DL, Han
L, Hang BI, Bai F, Pei XH, Nose V, Burlingame O, et al: Repurposing
the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic
agent for intestinal polyposis. PLoS One. 9:e1019692014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang W, Cheong JK, Ang SH, Teo B, Xu P,
Asari K, Sun WT, Than H, Bunte RM, Virshup DM and Chuah C:
Pyrvinium selectively targets blast phase-chronic myeloid leukemia
through inhibition of mitochondrial respiration. Oncotarget.
6:33769–33780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Trachootham D, Lu W, Carew J,
Giles FJ, Keating MJ, Arlinghaus RB and Huang P: Effective killing
of Gleevec-resistant CML cells with T315I mutation by a natural
compound PEITC through redox-mediated mechanism. Leukemia.
22:1191–1199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu Z, Jin Y, Qiu L, Lai Y and Pan J:
Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces
apoptosis in imatinib-resistant chronic myelogenous leukemia cells
harboring T315I mutation. Cancer Lett. 290:182–191. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu L, Wang XD, Yu BH, Lu RZ, Ge F, Wang
XL, Chen LJ, Han BH, Zhan ZM, Zhang BL and Ma J: Effect of a novel
tyrosine kinase inhibitor HHGV678 on growth inhibition of Bcr-Abl
wild type and IM-resistant cell lines in vitro. Zhongguo Shi Yan
Xue Ye Xue Za Zhi. 16:1039–1043. 2008.(In Chinese). PubMed/NCBI
|
|
20
|
Pan J, Quintas-Cardama A, Kantarjian HM,
Akin C, Manshouri T, Lamb P, Cortes JE, Tefferi A, Giles FJ and
Verstovsek S: EXEL-0862, a novel tyrosine kinase inhibitor, induces
apoptosis in vitro and ex vivo in human mast cells expressing the
KIT D816V mutation. Blood. 109:315–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Y, Chen Q, Shi X, Lu Z, Cheng C, Lai
Y, Zheng Q and Pan J: Activity of triptolide against human mast
cells harboring the kinase domain mutant KIT. Cancer Sci.
100:1335–1343. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin Y, Lu Z, Ding K, Li J, Du X, Chen C,
Sun X, Wu Y, Zhou J and Pan J: Antineoplastic mechanisms of
niclosamide in acute myelogenous leukemia stem cells: Inactivation
of the NF-kappaB pathway and generation of reactive oxygen species.
Cancer Res. 70:2516–2527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu B, Li J, Pan J, Huang B, Liu J and
Zheng D: Everolimus enhances the cytotoxicity of bendamustine in
multiple myeloma cells through a network of pro-apoptotic and
cell-cycle-progression regulatory proteins. Acta Biochim Biophys
Sin (Shanghai). 45:683–691. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi X, Jin Y, Cheng C, Zhang H, Zou W,
Zheng Q, Lu Z, Chen Q, Lai Y and Pan J: Triptolide inhibits Bcr-Abl
transcription and induces apoptosis in STI571-resistant chronic
myelogenous leukemia cells harboring T315I mutation. Clin Cancer
Res. 15:1686–1697. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan J, Xu G and Yeung SC: Cytochrome c
release is upstream to activation of caspase-9, caspase-8, and
caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer
cells induced by manumycin and paclitaxel. J Clin Endocrinol Metab.
86:4731–4740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blonska M, Shambharkar PB, Kobayashi M,
Zhang D, Sakurai H, Su B and Lin X: TAK1 is recruited to the tumor
necrosis factor-alpha (TNF-alpha) receptor 1 complex in a
receptor-interacting protein (RIP)-dependent manner and cooperates
with MEKK3 leading to NF-kappaB activation. J Biol Chem.
280:43056–43063. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Lou Y, Zheng X, Wang H, Sun J,
Dong Q and Han B: Wnt blockers inhibit the proliferation of lung
cancer stem cells. Drug Des Devel Ther. 9:2399–2407.
2015.PubMed/NCBI
|
|
28
|
Beck JW, Saavedra D, Antell GJ and Tejeiro
B: The treatment of pinworm infections in humans (enterobiasis)
with pyrvinium chloride and pyrvinium pamoate. Am J Trop Med Hyg.
8:349–352. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu MD, Xiong SJ, Tan F and Liu Y:
Physcion 8-O-β-glucopyranoside induces mitochondria-dependent
apoptosis of human oral squamous cell carcinoma cells via
suppressing survivin expression. Acta Pharmacol Sin. 37:687–697.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Basu D, Reyes-Mugica M and Rebbaa A: Role
of the beta catenin destruction complex in mediating
chemotherapy-induced senescence-associated secretory phenotype.
PLoS One. 7:e521882012. View Article : Google Scholar : PubMed/NCBI
|
